Thermogenesis Holdings (THMO) skyrockets over 80%
What’s up with Thermogenesis Holdings?
Thermogenesis Holdings (THMO) opened at $7.12, which means the stock is up 84.12% from yesterday’s closing price of 7.27. Today, the company has a high of $13.87 and a low of $6.76. The company has a market cap of $76.25 million with a 52-week high of $13.87 and a 52-week low of $1.63.
What about the future forThermogenesis Holdings
The high forecast for Thermogenesis Holdings is 20.00 while the low is 10.00. Stock forecasts are based on human experience: Human traders based on their experience in terms of stock price patterns, volume changes, and market news/rumors regarding a particular stock. Thermogenesis Holdings has a strong forecast. A strong forecast is a result of strong earning reports as investors are willing to pay a higher share price today because of growth expectations in the future.. Based on this information THMO seems to be a safe buy.
About Thermogenesis Holdings
ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. It operates through the Device and Clinical Development segment. The Device segment includes the development and commercialization of automated technologies for cell-based therapeutics and bioprocessing. The Clinical Development segment utilizes autologous stem cell-based therpeutics. The company was founded by Philip H. Coelho in 1986 and is headquartered in Rancho Cordova, CA.